TrialOncoimmunology2021

Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer.

Ze-Rui Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.